Nova Patents
NO902800L

11-Beta-aryl-4-estrene, method for its production and its use as a medicine

Abstract

This article describes the compounds of the general formula I, their preparation methods, compounds containing any of the compounds and its application in the treatment of disease. Invent compounds mainly on effects of pregnancy and effects of glucocorticoid resistance activity, X,R1,R2,R3 and meaning, see the instruction manual of the R4.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

39 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
3921059GermanyA
3921059GermanyA
893921059–––
DE19893921059–––

Members39

Family members, oldest first
DocumentOfficeKind
NO902800D0NorwayD0
HU903961D0HungaryD0
CA2019404A1CanadaA1
IE902280LIrelandL
EP0404283A2European Patent Office (EPO)A2
NO902800LThis recordNorwayL
CN1048219AChinaA
AU5778090AAustraliaA
DE3921059A1GermanyA1
IE902280A1IrelandA1
PT94462APortugalA
HUT54705AHungaryA
IL94819D0IsraelD0
ZA904893BSouth AfricaB
JPH03128323AJapanA
EP0404283A3European Patent Office (EPO)A3
DD295639A5German Democratic Republic (until 1990)A5
AU640664B2AustraliaB2
HU209949BHungaryB
IL94819AIsraelA
FI954748AFinlandA
NO178768BNorwayB
EP0404283B1European Patent Office (EPO)B1
AT137762TAustriaT
NO178768CNorwayC
DE59010312D1GermanyD1
GR3020098T3GreeceT3
DK0404283T3DenmarkT3
ES2088959T3SpainT3
CN1133296AChinaA
IE74191B1IrelandB1
US5728689AUnited States of AmericaA
US5843933AUnited States of AmericaA
JP2911553B2JapanB2
CN1048499CChinaC
CN1061052CChinaC
FI110688BFinlandB
CA2019404CCanadaC
FI111844BFinlandB